№ lp_1_2_23251
File format: docx
Character count: 61648
File size: 176 KB
The document provides a review of clinical guidelines and cost estimates regarding the use of anti-epileptic drugs (AEDs) for epilepsy treatment in Australia, considering the cost to the Pharmaceutical Benefits Scheme (PBS) for allowing first-line use of levetiracetam (LEV) and lamotrigine (LTG) in the general population.
Year:
2025
Region / city:
Australia
Subject:
Clinical guidelines, Anti-epileptic drugs, Epilepsy treatment
Document type:
Report
Organization:
Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Not specified
Target audience:
Healthcare professionals, policymakers, pharmaceutical industry stakeholders
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
April 2025
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Region / City:
Cleveland, OH
Theme:
Epilepsy Fellowship, Medical Education
Document Type:
Application Form
Institution:
University Hospitals Case Medical Center
Target Audience:
Medical professionals applying for a fellowship
Period of Action:
One year starting from the specified date
Contextual description:
Application form for candidates applying for an epilepsy fellowship at University Hospitals Case Medical Center, outlining required medical qualifications, training, and documentation.
Year:
Not specified
Region:
Not specified
Topic:
Epilepsy treatment and pregnancy risks
Document type:
Brochure
Institution:
Not specified
Target audience:
Women of childbearing potential with epilepsy
Drug focus:
Valproate
Other drugs mentioned:
Levetiracetam, Lamotrigine
Risk assessment:
Structural abnormalities, intelligence effects, autism spectrum disorders
Dosage guidance:
Dose-dependent risk levels
Pregnancy management:
Contraception recommendations, dose reduction strategies, monitoring guidelines
Year:
2023
Region / City:
England, Northern Ireland
Topic:
Mental Health, Epilepsy, Psychological Therapy
Document Type:
Clinical Trial Report
Organization:
UCL Great Ormond Street Institute of Child Health
Author:
Sophie D. Bennett, J. Helen Cross, Kashfia Chowdhury, Tamsin Ford, Isobel Heyman, Anna E. Coughtrey, Emma Dalrymple, Sarah Byford, Bruce Chorpita, Peter Fonagy, Rona Moss-Morris, Colin Reilly, Jonathan A. Smith, Terence Stephenson, Sophia Varadkar, James Blackstone, Harriet Quartly, Tyler Hughes, Amy Lewins, Elana Moore, Fahreen Walji, Alice Welch, Emily Whelan, Alice Zacharia, Anais D’Oelsnitz, Mariam Shah, Laila Xu, Aikaterini Vezyroglou, Kirsten Mitchell, Isabella E. Nizza, Poushali Ganguli, Roz Shafran
Target Audience:
Researchers, Clinicians, Policy Makers, Families
Period of Action:
August 2019 – February 2022
Approval Date:
Not specified
Date of Changes:
Not specified
Summary:
Randomised controlled trial assessing the effectiveness of the Mental Health Intervention for Children with Epilepsy (MICE) in treating mental health difficulties in children and young people with epilepsy, alongside usual care.
Year:
2025
Region / City:
United States
Theme:
Clinical Neuropsychology, Outcome Studies
Document Type:
Grant Program Announcement
Organization:
American Academy of Clinical Neuropsychology Foundation
Author:
American Academy of Clinical Neuropsychology Foundation
Target Audience:
Clinical Neuropsychologists, Psychologists, Graduate Students, Researchers
Period of Validity:
2025
Approval Date:
February 2, 2025
Amendment Date:
N/A
Year:
2021
Region / City:
Not specified
Topic:
Adherence to treatment, epilepsy
Document type:
Research article
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Note:
Year
Region / City:
Camperdown, Ashfield, Sydney
Topic:
Epilepsy, Neurology, Medical Training
Document Type:
Job Description
Organization:
Royal Prince Alfred Hospital
Author:
Not specified
Target Audience:
Medical professionals, Neurologists, Fellows in Epilepsy
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / City:
Zhejiang Province, China
Topic:
Epilepsy, Neuroscience
Document Type:
Research Article
Organization / Institution:
Zhejiang University
Author:
Lin Zhou, Liang Zhou, Li-Da Su, Sheng-Long Cao, Ya-Jun Xie, Ying Shen
Target Audience:
Researchers in neuroscience and epilepsy
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2015
Location:
Hamilton, New Zealand
Theme:
Annual General Meeting
Document Type:
Meeting Minutes
Organization:
Epilepsy Waikato Charitable Trust
Author:
Jill Davies, Chair
Target Audience:
Trust members and invited attendees
Period of Action:
13 October 2015
Approval Date:
13 October 2015
Date of Changes:
None
Year:
2025
Region / City:
Harare, Zimbabwe
Theme:
Epilepsy Care, Training
Document Type:
Report
Institution:
Epilepsy Support Foundation, Centre for Global Epilepsy, University of Zimbabwe
Author:
Prof Helen Cross, Prof Arjune Sen, Dr Gail Scher, Dr Gift Ngwende, Dr Jo Wilmshurst, Prof Sloan Mahone
Target Audience:
Healthcare professionals, advocates, people with lived experience of epilepsy
Period of validity:
12-14 February 2025
Approval Date:
12 February 2025
Date of Updates:
Not provided
Context:
Report on training courses focused on epilepsy management held in Zimbabwe in February 2025, including practical courses for healthcare professionals and awareness-building on stigma related to epilepsy.
Year:
2023
Region / city:
Global
Topic:
Pediatric Epilepsy, Therapeutic Diets, Neurology
Document Type:
Review Article
Institution:
N/A
Author:
Adelakin et al., Sharma et al., Hameed et al.
Target Audience:
Medical professionals, researchers, healthcare providers
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / city:
Glasgow, United Kingdom; London, United Kingdom
Topic:
Epilepsy, genetics, precision medicine, drug discovery
Document type:
Review article
Organization / institution:
Paediatric Neurosciences Research Group, Fraser of Allander Neurosciences Unit, Royal Hospital for Children, University of Glasgow, Imperial College London
Author:
Joseph D Symonds, Sameer M Zuberi, Michael R Johnson
Target audience:
Researchers, clinicians, healthcare professionals
Period of validity:
2023 onwards
Date of approval:
Not provided
Date of modifications:
Not provided
Year:
2026
Region / City:
Not specified
Subject:
Lipid mediators in epilepsy
Document type:
Supplementary tables and figures
Institution:
Not specified
Authors:
Not specified
Study population:
Patients with chronic epilepsy (n=8) and controls (n=6)
Methods:
LC-MS-MS analysis of plasma and cerebrospinal fluid
Analytes:
DHA, EPA, AA, resolvins, hydroxy-fatty acids, prostaglandins, lipoxins, leukotrienes
Variables analyzed:
Gender, seizure types, number of antiseizure medicines, age
Statistical analysis:
P values, multiple linear regression
Scale:
National Hospital Seizure Severity Scale (NHS3)
Correlation measures:
Plasma and CSF levels of RvD1 and RvE1 with clinical parameters
Document type:
Medical support plan form
Subject:
Epilepsy seizure management and support
Medical condition:
Epilepsy
Purpose:
Recording seizure characteristics, triggers, and support requirements
Key sections:
General information; Emergency medication status; Seizure triggers; Behavioural warning signs; Seizure description and frequency; Support during seizure; Post-seizure support; Risk and safety alerts; Overnight support
Medical information recorded:
Seizure types, duration, frequency, emergency medication instructions
Associated documents:
Medication authority; Emergency medication plan; Seizure records; General support needs document
Responsible coordinator:
Plan coordinator (name, organisation, telephone, relationship to person)
Medical endorsement:
Treating doctor name, telephone, signature, and date
Target individuals:
Person living with epilepsy and their carers, guardians, or support workers
Year:
2023
Region / City:
Global
Topic:
Epilepsy, Seizure Patterns
Document Type:
Research Supplementary Material
Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Medical Professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Month:
November
Region / Country:
Australia
Programme:
National Disability Insurance Scheme (NDIS)
Topic:
Epilepsy management and seizure response in people with disability
Document Type:
Practice alert / clinical guidance
Target Group:
NDIS providers and support workers
Subject Population:
People with intellectual disability and epilepsy
Medical Field:
Neurology and disability support care
Key Focus:
Seizure recognition, epilepsy management planning, and risk reduction
Recommended Review Period:
Every 12 months
Responsible Professionals:
General practitioners, neurologists, specialist doctors, disability support providers
Main Components:
Seizure types, seizure triggers, epilepsy management plans, emergency response procedures, risk factors, medication management, seizure documentation
Risk Areas:
Falls, burns, drowning, aggression, sudden unexpected death in epilepsy
Clinical Tools Referenced:
Epilepsy management plan, seizure chart, seizure detection devices